Tool gives more accurate estimates of recurrence risk and individual chemotherapy benefit in node-positive breast cancer

A new statistical tool that combines multiple clinical and pathologic factors with a patient’s 21-gene Oncotype DX Breast Recurrence Score result provides more accurate estimates about that patient’s breast cancer prognosis and their potential benefit from chemotherapy than either the Recurrence Score result or clinical factors alone.

US college graduates live an average of 11 years longer than those who never finish high school, study finds

Across more than 3,000 US counties, vast geographic differences with a widening gap were registered between the least and most educated, with a longer lifespan for those with a higher level of education. That’s according to the latest analysis by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington’s School of Medicine that was published in The Lancet Public Health.